The trial aims to evaluate the therapy’s tolerability, pharmacokinetics and safety in around 56 healthy volunteers.

Clinical-stage biopharmaceutical company CuraSen Therapeutics has treated the first subject in the Phase I trial of CuraAX to treat neurogenic orthostatic hypotension (nOH). The trial aims to ...

Discover the powerful herbs and vitamins that support neurogenesis and neuroprotection, promoting brain health and resilience ...

EG 427 SAS has closed a €27 million (US$28.3 million) series B round, which will fund it to completion of the first clinical ...

Characterised by a sudden blood pressure drop upon standing, nOH often leads to dizziness and cognitive issues. Credit: Prostock-studio/Shutterstock. Clinical-stage ...

The aim of this study was to assess the feasibility of a bowel management program for patients with neurogenic bowel function after spinal cord injury. The program is based on evidence-based nursing, ...

People assigned female at birth have a predisposition for migraines, especially in adolescence and around menopause. Find a ...

US net sales, recognized by Viatris, reached an all-time high of $66.7 million in Q4 2024 and $238.6 million in FY 2024, up 10% and 8%, respectively ...

Pro-inflammatory signaling represses reprogramming of mouse MG by promoting reactivity networks and anti-neurogenic factors, while increasing cell death in damage retinas (Palazzo et al., 2022).